Tango Therapeutics, Inc.
News
Tango Therapeutics (NASDAQ:TNGX) Stock Rating Reaffirmed by HC Wainwright
Ticker Report Tango Therapeutics (NASDAQ:TNGX - Get Free Report)s stock had its "buy" rating restated by stock analysts at HC Wainwright in a research report issued on Tuesday, Benzinga reports. They...\n more…
Rock Ventures Iv L.P. Third Sells 75,000 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) Stock
Ticker Report Tango Therapeutics, Inc. (NASDAQ:TNGX - Get Free Report) major shareholder Rock Ventures Iv L.P. Third sold 75,000 shares of the business's stock in a transaction on Thursday, September 5th. The...\n more…
Tango Therapeutics: Amgen Missteps Devalue PRMT5 Candidates Ahead Of Critical Data
Seeking Alpha - Long Ideas Tango Therapeutics: Amgen Missteps Devalue PRMT5 Candidates Ahead Of Critical Data...\n more…
Analyst Scoreboard: 4 Ratings For Tango Therapeutics
Benzinga During the last three months, 4 analysts shared their evaluations of Tango Therapeutics TNGX, revealing diverse outlooks from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.\n more…
Notable Two Hundred Day Moving Average Cross - TNGX
Market News Video In trading on Monday, shares of Tango Therapeutics Inc (TNGX) crossed below their 200 day moving average of 9.33, changing hands as low as 8.18 per share. Tango Therapeutics Inc shares are...\n more…
Tango Therapeutics (TNGX) Gets a Buy from Piper Sandler
TipRanks Financial Blog In a report released today, Joseph Catanzaro from Piper Sandler maintained a Buy rating on Tango Therapeutics (TNGX - Research Report), with a pric...\n more…